DR ABBAS — All Prescriptions & Medications
Practice Code: K83618 | NORTHAMPTON, NN3 8DW
Over the last 12 months, DR ABBAS prescribed 177,728 items across 517 different medications at a total cost of £1,252,627 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Aclidinium bromide/formoterol | 10 | 10 | £309 | -71.6% ▼ |
| Opicapone | 10 | 280 | £551 | -47.8% ▼ |
| Amantadine hydrochloride | 10 | 560 | £135 | -64.1% ▼ |
| Ins degludec/liraglutide | 10 | 30 | £955 | -37.8% ▼ |
| Bicalutamide | 10 | 280 | £22 | -69.1% ▼ |
| Heparinoid | 10 | 1,250 | £68 | -61.9% ▼ |
| 10 | 1,080 | £34 | -80.0% ▼ | |
| 10 | 400 | £557 | -21.5% ▼ | |
| 10 | 300 | £2.0K | -1.6% vs avg | |
| Lacidipine | 11 | 308 | £27 | -90.8% ▼ |
| Terbutaline sulphate | 11 | 11 | £87 | -79.7% ▼ |
| Lofepramine hydrochloride | 11 | 896 | £376 | -63.2% ▼ |
| Reboxetine | 11 | 628 | £189 | -28.6% ▼ |
| Canagliflozin/metformin | 11 | 660 | £410 | -26.5% ▼ |
| Somatropin | 11 | 22 | £2.0K | -22.4% ▼ |
| Sodium clodronate | 11 | 624 | £1.4K | +1.9% vs avg |
| Octreotide acetate | 11 | 11 | £8.8K | +77.0% ▲ |
| Cinacalcet hydrochloride | 11 | 308 | £76 | -52.6% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 11 | 30.8K | £753 | +3.1% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 11 | 4,200 | £64 | -52.0% ▼ |
| Diethylamine salicylate | 11 | 1,050 | £33 | -59.3% ▼ |
| Carbomer 974P | 11 | 220 | £94 | +35.8% ▲ |
| Ciprofloxain/dexameth | 11 | 55 | £64 | -64.2% ▼ |
| 11 | 55 | £31 | +5.9% ▲ | |
| 11 | 11 | £101 | +10.0% ▲ | |
| Trimetazidine hydrochloride | 12 | 720 | £1.2K | +47.7% ▲ |
| Fluticasone/umeclidinium/vilanterol | 12 | 12 | £507 | -94.9% ▼ |
| Hydroxyzine hydrochloride | 12 | 672 | £21 | -77.5% ▼ |
| Rifaximin | 12 | 672 | £3.1K | -55.3% ▼ |
| Diclofenac sodium | 12 | 221 | £47 | -76.4% ▼ |
| Indometacin | 12 | 672 | £42 | -23.7% ▼ |
| Ketoprofen | 12 | 1,200 | £52 | -66.6% ▼ |
| Betaxolol | 12 | 60 | £28 | +26.2% ▲ |
| 12 | 60 | £170 | -43.2% ▼ | |
| 12 | 120 | £10 | -29.0% ▼ | |
| 12 | 30 | £175 | -56.9% ▼ | |
| 12 | 39 | £175 | -70.5% ▼ | |
| 12 | 1,200 | £178 | +2.8% ▲ | |
| 12 | 470 | £2.1K | +2.2% ▲ | |
| Methyldopa | 13 | 1,154 | £169 | -23.7% ▼ |
| Moxonidine | 13 | 364 | £59 | -76.6% ▼ |
| Olmesartan medoxomil | 13 | 364 | £20 | -81.1% ▼ |
| Colesevelam hydrochloride | 13 | 2,340 | £892 | -65.7% ▼ |
| Fluvastatin sodium | 13 | 364 | £51 | -43.8% ▼ |
| Lithium carbonate | 13 | 1,456 | £199 | -89.8% ▼ |
| Atomoxetine hydrochloride | 13 | 364 | £748 | -61.6% ▼ |
| Guanfacine | 13 | 364 | £749 | -49.4% ▼ |
| Domperidone | 13 | 1,110 | £23 | -63.6% ▼ |
| Aspirin combined preparations | 13 | 1,170 | £105 | +153.2% ▲ |
| Urine testing reagents | 13 | 650 | £37 | +16.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.